Why was Remdesivir the first drug against COVID-19 to be recommended for EU authorisation?
Remdesivir was the first medicine against COVID-19 to be recommended for authorisation in the EU.
Remdesivir is vastly more profitable than hydroxychloroquine.
Hydroxychloroquine costs about 60 US cents per pill. Remdesivir costs about $1,000 per pill.